Pancreas Transplant Outcomes

At a Glance

• First transplant: 05/11/87
• Transplants performed in 2024: 2
• Total number of program transplants through 2024: 181
• Received Medicare approval: 07/01/99

Outcomes

• Pre-transplant mortality#: .064 (expected .029, national .047)
  

Adult one- and three-year patient survival rates for PAK (pancreas after kidney transplant)*:

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford one-year expected patient survival rate^: 98.30%
• Henry Ford three-year patient survival rate: 100.00%
• Henry Ford three-year expected patient survival rate^: 99.37%

Adult one year patient survival rates for SPK*:

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford one-year expected patient survival rate^: 97.28%
• Henry Ford three-year patient survival rate^: 100.00%
• Henry Ford three-year expected patient survival rate^: 95.26%

# Patients on the waitlist between 07/01/2022 and 06/30/2024.
*Estimated probability of surviving at one year, for patients receiving their first transplant between 7/01/2021 and 12/31/2023; and at three years between for patients receiving their first transplant between 1/01/2019 and 03/12/2020, and 06/13/2020 and 06/30/2021.
^ Adjusted for patient and donor characteristics.

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available October 31, 2024, released January 7, 2025.